Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05679557 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy

Study acronym: COMPETENCE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 27, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Primary completion date: Apr 1, 2025 to Apr 1, 2026v5
  3. Secondary endpoints: details revised at 2 of 8 entriesv4
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1v3 Show 1 more changeShow less
    • Study sites: 0 to 1
  5. Secondary endpoints: details revised at 2 of 8 entries Study title shortened, about 5 wordsv2 Show 1 more changeShow less
    • Study title shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with muscle-invasive bladder cancer are often older and multimorbid, thus in an increased risk of perioperative mortality and morbidity in relation to radical cystectomy (RC). The aim of the study is to investigate the effect of perioperative Comprehensive Geriatric Assessment (CGA) and tailored intervention in older, frail patients with bladder cancer undergoing RC.
Trial Details
NCT Number NCT05679557
Lead Sponsor Aarhus University Hospital
Collaborators: University of Aarhus, Aalborg University Hospital, Odense University Hospital
Conditions Bladder Cancer
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov